Cancer can and does develop in the foot, though it is uncommon enough that many people and even some clinicians overlook the possibility. A ten-year review at one institution found 195 foot tumors, of which about one in four turned out to be malignant. The foot can host skin cancers, soft-tissue sarcomas, primary bone tumors, and even metastases that have traveled there from cancers elsewhere in the body. Because the foot is rarely inspected closely, these cancers tend to be caught later than cancers on more visible body parts, which makes knowing the warning signs genuinely useful.
How Common Are Foot Tumors
Most lumps and bumps on the foot are benign. In a retrospective analysis of 195 foot tumors over a decade, 148 were benign and 47 were malignant.1Journal of Orthopaedic Surgery. Tumours of the foot: A 10 years retrospective analysis Ganglion cysts, giant cell tumors of the tendon sheath, and plantar fibromas account for a large share of the benign growths. The malignant minority, though, spans a surprisingly wide range of cancer types. That variety is part of what makes foot cancer tricky: there is no single “foot cancer” to watch for, but rather a collection of different diseases that happen to share a location.
Skin Cancers That Affect the Foot
Melanoma
Melanoma on the foot is the skin cancer that gets the most attention, and for good reason. The subtype that favors the sole, the area under the toenails, and the sides of the toes is called acral lentiginous melanoma. Unlike the melanomas people typically picture on sun-exposed skin, acral melanoma has nothing to do with UV exposure. It occurs across all skin tones and is the most common form of melanoma in people with darker skin.
The signs patients themselves notice tend to be bleeding, a spot larger than about six millimeters, a change in size, a change in shape, or a raised area on previously flat skin. In one study of 43 patients with acral melanoma, bleeding and size greater than six millimeters were each reported by roughly 42% of patients, while a change in color showed up in about 21%.2Journal of Cosmetic Dermatology. Acral lentiginous melanoma: A retrospective study Under or around a toenail, melanoma can produce a dark streak running the length of the nail. When that dark pigment spills onto the skin of the nail fold, it is called the Hutchinson sign, and it raises strong suspicion for melanoma.3PubMed Central. Trauma-Associated Pseudo-Hutchinson Sign: An Autobiographical Case Report Emphasizing Conditions, Pseudo-Conditions, and Pseudo-Pseudo-Conditions
An intriguing finding connects melanoma location on the sole with mechanical stress. Researchers analyzing 153 acral melanomas found that weight-bearing regions of the foot, particularly the heel and ball of the foot, harbored significantly more melanomas than the arch, which bears little pressure during walking.4Scientific Reports. A clinicopathological analysis of 153 acral melanomas and the relevance of mechanical stress The mechanism behind that association is still debated, but chronic friction and pressure-related tissue changes are suspected contributors.
Foot melanoma tends to be diagnosed at a more advanced stage than melanoma elsewhere. One analysis found the five-year survival rate for melanoma of the toe was about 50%, and ulceration of the lesion was independently tied to worse outcomes.5Journal of Foot and Ankle Surgery. Melanoma of the Foot Is Associated With Advanced Disease and Poorer Survival That statistic is not inherent to the biology of toe melanoma; it largely reflects the fact that people do not examine their feet the way they might scan a mole on their arm.
Squamous Cell Carcinoma and Marjolin’s Ulcer
Squamous cell carcinoma is the other skin cancer that foot and ankle specialists see with some regularity. It can arise on its own, but a well-known pattern on the foot involves chronic wounds or scars that undergo malignant transformation, a phenomenon called Marjolin’s ulcer. These lesions most often appear as well-differentiated squamous cell tumors and favor the heel and plantar surface.6PubMed Central. A Comprehensive Review on Marjolin’s Ulcers: Diagnosis and Treatment Chronic neuropathic wounds, venous stasis ulcers, and pressure sores can all serve as the starting point.7The Journal of Foot and Ankle Surgery. Squamous Cell Carcinoma of the Heel Presenting as a Chronic Pressure Ulcer: A Case Report and Review of the Literature
For people with diabetes, this is a particular concern. A diabetic foot ulcer that will not heal, especially one with irregular, hardened, or crusted edges, warrants a biopsy to rule out malignant transformation.8PubMed Central. Atypical diabetic foot ulcer turning into squamous cell carcinoma The transformation from chronic wound to cancer can take years, so a wound that has been stable for a long time and then starts to change deserves fresh suspicion.
Verrucous Carcinoma
Verrucous carcinoma is a slow-growing, low-grade variant of squamous cell carcinoma that deserves its own mention because of a specific diagnostic pitfall: it looks almost exactly like a plantar wart. Clinicians have repeatedly mistaken it for a stubborn wart, treating it with cryotherapy or topical agents for months before eventually biopsying it.9PubMed. Verrucous carcinoma of the foot, not your typical plantar wart: a case study A wart-like growth on the sole that does not respond to standard treatment should be biopsied rather than repeatedly frozen.
Soft-Tissue Sarcomas in the Foot
Synovial Sarcoma
Despite its misleading name, synovial sarcoma does not actually arise from the synovial lining of joints. It is a high-grade soft-tissue malignancy that has a well-documented preference for the extremities, including the foot and ankle.10Foot & Ankle Surgery: Techniques, Reports & Cases. Rare presentation of synovial sarcoma in the foot: A case study It tends to strike younger people. In one institutional review of 84 patients, the median age at diagnosis for those with localized disease was 36 years.11American Journal of Clinical Oncology. Synovial Sarcoma of the Hand and Foot: An Institutional Review
Patients typically notice a slowly enlarging mass, sometimes painful and sometimes not. In one series, symptoms had been present for a median of 14 months before diagnosis, and about half of the patients eventually developed lung metastases, all of whom died from their disease.12PubMed. Synovial sarcoma of the foot and ankle That long symptom-to-diagnosis gap is typical: a painless lump on the foot gets attributed to a cyst, a sprain, or just an oddity, and by the time someone investigates, the window for early treatment has narrowed. Interestingly, the same study found that patients who had longer symptom durations before diagnosis actually did better, presumably because their tumors were biologically less aggressive to begin with.
Imaging can add to the confusion. In one case report, initial imaging of a foot mass suggested a benign hemangioma; only after surgical excision did molecular analysis reveal monophasic synovial sarcoma with its characteristic gene fusion.10Foot & Ankle Surgery: Techniques, Reports & Cases. Rare presentation of synovial sarcoma in the foot: A case study The lesson for patients is that a growing mass on the foot deserves imaging and, often, a biopsy rather than watchful waiting.
Clear Cell Sarcoma
Clear cell sarcoma is sometimes called “malignant melanoma of soft parts” because its cells look similar to melanoma cells under a microscope and share a neural crest origin. It typically presents in the lower legs and feet of young adults, attached to tendons or their surrounding tissue.13PubMed. Clear cell sarcoma of tendons and aponeuroses: a review The foot and ankle are among the most common sites.14PubMed Central. Significance of MRI in the diagnosis and differentiation of clear cell sarcoma of tendon and aponeurosis (CCSTA) A case report Because of its rarity, clear cell sarcoma is almost always diagnosed by biopsy rather than clinical appearance alone.
Kaposi Sarcoma
Kaposi sarcoma is most widely known as an AIDS-associated cancer, but a “classic” form also occurs in people with intact immune systems, particularly older men of Mediterranean or Eastern European descent. It typically shows up as dark patches or plaques on the lower legs and feet.15PubMed Central. Clinical challenge: cutaneous Kaposi’s sarcoma of the lower extremity In one reported case, a 60-year-old immunocompetent man developed a rapidly growing lesion on the sole of his foot that turned out to be classic Kaposi sarcoma positive for the herpesvirus (HHV-8) that drives the disease.16Wounds. Classic Solitary Kaposi Sarcoma of the Foot in an Immunocompetent Patient: A Case Report Surgical excision was curative in that instance, but the point is that a dark, vascular-looking growth on the foot is not always a bruise or a blood blister.
Bone Tumors in the Foot
Primary bone cancers of the foot are quite rare but do exist. A review identified 55 primary malignant bone tumors of the foot over a multi-decade period, accounting for most of the malignant bone cases studied.17PubMed Central. Malignant bone tumours of the foot Chondrosarcoma and Ewing sarcoma are among the types that have been documented. Symptoms tend to be nonspecific: persistent pain, swelling, or a palpable mass in the foot that does not resolve with rest. Because the foot contains 26 bones packed into a small space, tumors can affect mechanics early, sometimes presenting as unexplained limping or difficulty wearing shoes before anyone suspects cancer.
When Cancer Travels to the Foot
The foot can also be the landing site for metastases from cancers originating elsewhere. A review of the literature found that the most common primary cancers sending metastases to the foot were lung cancer (about 28%), endometrial cancer (about 17%), and breast cancer (about 11%).18PubMed Central. Foot metastasis: Current knowledge The calcaneus, or heel bone, was the single most frequent target, followed by the talus. This makes clinical sense: the calcaneus has a rich blood supply relative to other foot bones, giving circulating tumor cells more opportunity to lodge there.
Foot metastases are rare overall, but they matter because they can be the first sign that a cancer exists. A person with unexplained heel pain and a destructive bone lesion on X-ray may end up being diagnosed with lung or kidney cancer. Anyone with a known cancer history who develops new, persistent foot pain should mention that history to their doctor, since the connection may not be obvious to a clinician focused on the foot.
Why Foot Cancer Gets Misdiagnosed
Delayed and incorrect diagnosis is one of the most consequential problems with foot cancer. In a study of 107 patients with melanoma on the foot, 30% were misdiagnosed at their first medical visit. Nearly half of those misdiagnoses were wounds, diabetic ulcers, trauma, or vascular disease.19PubMed Central. Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis The consequences of that delay were not trivial: initial misdiagnosis was associated with worse outcomes.
Several factors conspire to produce these errors. The sole of the foot is simply hard to see, and people rarely inspect it. Many foot cancers mimic common conditions: melanoma under a toenail can look like a fungal infection or a bruise from a stubbed toe; verrucous carcinoma mimics a wart; squamous cell carcinoma in a chronic wound looks like more of the same wound. Clinicians who see foot complaints every day are accustomed to benign explanations, and cancer is so uncommon in this location that it may not make the initial list of possibilities. In a case series of soft-tissue sarcomas of the foot, half the patients had already undergone an unplanned excision, meaning a surgeon had removed the mass without suspecting cancer and without obtaining adequate margins.20PubMed Central. Soft-tissue sarcoma of the foot
The practical takeaway is simple: if you have a lesion on your foot that is growing, bleeding, changing color, or not healing as expected, push for a biopsy rather than accepting prolonged empirical treatment. Early biopsy is cheap compared to the cost of a delayed cancer diagnosis.
How Foot Cancer Is Diagnosed
MRI is the workhorse imaging tool for evaluating soft-tissue masses in the foot. It shows the exact location and extent of a tumor, its relationship to tendons and bones, and certain internal characteristics that help distinguish benign from malignant growths. In one early study, MRI correctly identified 86% of foot tumors as benign or malignant, and it suggested the specific diagnosis in most benign cases.21PubMed. Soft-tissue tumors of the foot: value of MR imaging for specific diagnosis More recent reviews confirm that MRI remains central to narrowing the differential diagnosis for foot and ankle soft-tissue masses.22PubMed Central. Review of Soft Tissue Masses of the Foot and Ankle: Magnetic Resonance Imaging Features
Imaging alone, however, cannot definitively diagnose most malignancies. Biopsy remains essential. For skin lesions, a punch or excisional biopsy provides the tissue needed for histopathology. For deeper masses, a needle biopsy or incisional biopsy guided by imaging is standard. The biopsy should ideally be planned by or in consultation with the surgeon who would perform the definitive operation, because a poorly placed biopsy track can complicate later surgery.
Treatment and Limb Preservation
One of the biggest fears people have about foot cancer is amputation. While amputation is sometimes necessary, especially for very large or strategically located tumors, modern treatment has shifted heavily toward limb-sparing approaches. In a study of soft-tissue sarcomas of the foot and ankle, limb salvage was achieved in most patients, with some requiring free tissue transfers to cover surgical defects.23Foot & Ankle International. Soft Tissue Sarcomas of the Foot and Ankle: Impact of Unplanned Excision, Limb Salvage, and Multimodality Therapy Combining surgery with radiation therapy has proven effective for sarcomas in the hands and feet, providing strong local control while preserving function.24PubMed. Combined Limb-Sparing Surgery and Radiation Therapy to Treat Sarcomas of the Hands and Feet: Long-Term Cancer Outcomes and Morbidity Even when local recurrence happened, salvage without amputation was often still possible.
Reconstruction after tumor removal from the foot presents unique challenges because the foot has to bear weight. For defects on the sole, surgeons sometimes use specialized flaps that match the thickness and texture of plantar skin. One technique uses tissue from the arch of the opposite foot, a medial plantar flap, which can be connected to nerves to restore some sensation and anchored firmly enough to withstand the shearing forces of walking.25Plastic and Reconstructive Surgery – Global Open. Successful Balanced Gait after Reconstruction of the Weight-bearing Mid Plantar Region Using a Free Contralateral Medial Plantar Flap For bone defects, such as after removal of the entire calcaneus, reconstructions using bone grafts from the patient’s own fibula combined with donor bone have shown strong functional results, with patients returning to full weight-bearing in an average of about seven months.26Journal of Surgical Oncology. Composite biological reconstruction following total calcanectomy of primary calcaneal tumors
Outcomes after foot cancer surgery depend heavily on the specific cancer, its stage, and whether the initial excision was properly planned. This is why referral to a specialist center matters: unplanned excisions by clinicians who were not expecting cancer frequently leave residual disease and complicate the definitive surgery.
Foot Cancer in Children
Children are not exempt. Rhabdomyosarcoma, the most common soft-tissue sarcoma in childhood, can arise in the hand or foot. The outlook for foot rhabdomyosarcoma is more guarded than for the same tumor at many other sites. In one study, half of the children with hand or foot rhabdomyosarcoma had metastatic disease at the time of diagnosis, and five-year survival was 33%, compared to 56% for rhabdomyosarcoma at other extremity locations.27PubMed. Rhabdomyosarcoma of the extremities: a focus on tumors arising in the hand and foot Complete surgical removal was achieved in only one of the twelve hand and foot cases, reflecting how difficult it is to get clean margins in the tight anatomy of the foot.
The Children’s Oncology Group has reported on local therapy strategies for these tumors and found that radiation therapy can provide excellent local control, with ten-year local control reaching 100% in their cohort. Ten-year overall survival was about 63%, with no difference between patients treated with surgery versus radiation for local management.28PubMed Central. Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children’s Oncology Group Gross residual disease and lymph node involvement predicted recurrence. The findings suggest that amputation is often avoidable in pediatric foot rhabdomyosarcoma when chemotherapy and radiation are part of the treatment plan, which is encouraging news for families facing this diagnosis.
Signs Worth Checking For
Because the foot hosts such a varied collection of potential cancers, no single checklist covers everything. But a few patterns should prompt medical attention:
- Dark streak under a toenail: A longitudinal pigmented band, especially one that widens over time or extends onto the surrounding skin, needs evaluation for subungual melanoma.
- Changing mole or spot on the sole: Any new or evolving pigmented lesion on the bottom of the foot, particularly on the heel or ball, deserves inspection. Bleeding, irregular borders, and color changes are red flags.
- Non-healing wound: A chronic ulcer, especially one associated with diabetes or vascular disease, that develops raised, hardened, or crusted edges may be undergoing malignant transformation.
- Persistent lump: A soft-tissue mass that is growing, even if it is painless, should be imaged and potentially biopsied. Many sarcomas present as painless lumps that are only noticed when they reach a certain size.
- Unexplained bone pain: Persistent, deep pain in the foot that does not correlate with an injury and does not improve with rest warrants imaging to rule out both primary bone tumors and metastases.
- Wart that won’t respond to treatment: A plantar wart that remains unchanged or grows despite multiple rounds of standard therapy could be verrucous carcinoma.
None of these signs is specific to cancer. Most dark streaks under nails are benign, most lumps are cysts, and most non-healing wounds are just non-healing wounds. But a biopsy is a small intervention with a large potential payoff, and the consistent thread running through the research on foot cancer is that delays in diagnosis, often measured in months or years, drive much of the poor outcomes seen in this location.
When the Whole Foot Needs Rebuilding
Reconstruction deserves a closer look because it so directly affects quality of life. The foot is a mechanical structure that has to absorb and distribute force with every step. Removing a tumor and closing the wound is only half the challenge; restoring the ability to walk comfortably is the other half. In a series from a cancer center in northeast India, 21 patients underwent reconstruction after foot tumor resections using techniques ranging from simple skin grafts to local flaps to free tissue transfers, with the choice driven by the location and size of the defect. For weight-bearing areas, free tissue transfer was considered the best option for acceptable long-term function.29PubMed Central. Reconstruction and Outcome of Foot Defects Following Oncological Resection-Experience from a Cancer Centre in North-East India
Ankle sarcoma patients face a particularly difficult trade-off between cancer control and mobility. A study comparing minor limb salvage, major limb salvage, and amputation for ankle sarcomas aimed to measure differences in surgical outcomes and quality of life across these three approaches.30The Bone & Joint Journal. Complications, mobility, and quality of life in ankle sarcoma patients The complexity of this decision underscores why treatment planning for foot and ankle cancers benefits from a multidisciplinary team, one that includes not just the oncologist and surgeon but also a reconstruction specialist and a rehabilitation professional who understands what the foot will need to do once healing is complete.